4.5 Review

Mycoses of implantation in Latin America: an overview of epidemiology, clinical manifestations, diagnosis and treatment

期刊

MEDICAL MYCOLOGY
卷 49, 期 3, 页码 225-236

出版社

OXFORD UNIV PRESS
DOI: 10.3109/13693786.2010.539631

关键词

subcutaneous mycoses; endemic mycoses; posaconazole; itraconazole

资金

  1. Schering-Plough
  2. Merck Co., Inc.
  3. Astellas
  4. Janssen
  5. Merck
  6. Pfizer
  7. United Medical

向作者/读者索取更多资源

Implantation or subcutaneous mycoses are a frequent health problem in Latin American countries and other tropical and subtropical areas. Although such infections rarely cause disseminated or invasive disease, they have an important impact on public health, and timely diagnosis and appropriate treatment remain important. Although some implantation mycoses are found in immunocompromised persons, the immunocompetent population is the principal target in Latin America. Most etiologic agents are found in soil, vegetation, and decaying matter in tropical, subtropical, and humid environments and infection is commonly the result of penetrating injury. Infections primarily occur (1) among low socioeconomic groups, (2) among those living in rural areas or involved in farming, hunting, or other outdoor activities, and (3) particularly among adult men. This review focuses on the epidemiology of the most clinically significant implantation mycoses in Latin America, i.e., sporotrichosis, eumycetoma, chromoblastomycosis, subcutaneous phaeohyphomycosis, subcutaneous zygomycosis, and lacaziosis. Main epidemiologic findings, clinical manifestations, diagnosis, and treatment options are also discussed.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据